Inhibiting endothelin-1 receptor binding reduced ovarian cancer cell metastasis in vivo and impaired the expression of IQGAP1 and other invadopodia effectors in the metastasized tumors [162]. This evidence concerns the gene IQGAP1 and ovarian carcinoma.